Literature DB >> 16808776

Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial.

Jose Labarere1, Roslyn A Stone, D Scott Obrosky, Donald M Yealy, Thomas P Meehan, Thomas E Auble, Jonathan M Fine, Louis G Graff, Michael J Fine.   

Abstract

BACKGROUND: Many low-risk patients with pneumonia are hospitalized despite recommendations to treat such patients in the outpatient setting.
OBJECTIVE: To identify the factors associated with the hospitalization of low-risk patients with pneumonia.
METHODS: We analyzed data collected by retrospective chart review for 1,889 low-risk patients (Pneumonia Severity Index [PSI] risk classes I to III without evidence of arterial oxygen desaturation) enrolled in a cluster-randomized trial conducted in 32 emergency departments.
RESULTS: Overall, 845 (44.7%) of all low-risk patients were treated as inpatients. Factors independently associated with an increased odds of hospitalization included PSI risk classes II and III, the presence of medical or psychosocial contraindications to outpatient treatment, comorbid conditions that were not contained in the PSI (cognitive impairment, history of coronary artery disease, diabetes mellitus, or pulmonary disease), multilobar radiographic infiltrates, and home therapy with oxygen, corticosteroids, or antibiotics before presentation. While 32.8% of low-risk inpatients had a contraindication to outpatient treatment and 47.1% had one or more preexisting treatments, comorbid conditions, or radiographic abnormalities not contained in the PSI, 20.1% had no identifiable risk factors for hospitalization other than PSI risk class II or III.
CONCLUSIONS: Hospital admission appears justified for one-third of low-risk inpatients based upon the presence of one or more contraindications to outpatient treatment. At least one-fifth of low-risk inpatients did not have a contraindication to outpatient treatment or an identifiable risk factor for hospitalization, suggesting that treatment of a larger proportion of such low-risk patients in the outpatient setting could be achieved without adversely affecting patient outcomes.

Entities:  

Mesh:

Year:  2006        PMID: 16808776      PMCID: PMC1924717          DOI: 10.1111/j.1525-1497.2006.00510.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  22 in total

1.  Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria.

Authors:  B Rosón; J Carratalà; J Dorca; A Casanova; F Manresa; F Gudiol
Journal:  Clin Infect Dis       Date:  2001-06-15       Impact factor: 9.079

2.  The emergency department community-acquired pneumonia trial: Methodology of a quality improvement intervention.

Authors:  Donald M Yealy; Thomas E Auble; Roslyn A Stone; Judith R Lave; Thomas P Meehan; Louis G Graff; Jonathan M Fine; D Scott Obrosky; Stacey M Edick; Linda J Hough; Kathy Tuozzo; Michael J Fine
Journal:  Ann Emerg Med       Date:  2004-06       Impact factor: 5.721

3.  Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia?

Authors:  P B Hasley; M N Albaum; Y H Li; C R Fuhrman; C A Britton; T J Marrie; D E Singer; C M Coley; W N Kapoor; M J Fine
Journal:  Arch Intern Med       Date:  1996-10-28

4.  A prediction rule to identify low-risk patients with community-acquired pneumonia.

Authors:  M J Fine; T E Auble; D M Yealy; B H Hanusa; L A Weissfeld; D E Singer; C M Coley; T J Marrie; W N Kapoor
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

5.  Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.

Authors:  Christopher H Goss; Gordon D Rubenfeld; David R Park; Vandy L Sherbin; Michelle S Goodman; Richard K Root
Journal:  Chest       Date:  2003-12       Impact factor: 9.410

6.  2002 National Hospital Discharge Survey.

Authors:  Carol J DeFrances; Margaret J Hall
Journal:  Adv Data       Date:  2004-05-21

7.  Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia.

Authors:  C M Coley; Y H Li; A R Medsger; T J Marrie; M J Fine; W N Kapoor; J R Lave; A S Detsky; M C Weinstein; D E Singer
Journal:  Arch Intern Med       Date:  1996-07-22

8.  Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis.

Authors:  M J Fine; M A Smith; C A Carson; S S Mutha; S S Sankey; L A Weissfeld; W N Kapoor
Journal:  JAMA       Date:  1996-01-10       Impact factor: 56.272

Review 9.  Testing strategies in the initial management of patients with community-acquired pneumonia.

Authors:  Joshua P Metlay; Michael J Fine
Journal:  Ann Intern Med       Date:  2003-01-21       Impact factor: 25.391

10.  Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.

Authors:  Lionel A Mandell; John G Bartlett; Scott F Dowell; Thomas M File; Daniel M Musher; Cynthia Whitney
Journal:  Clin Infect Dis       Date:  2003-11-03       Impact factor: 9.079

View more
  15 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  The potential impact of biomarker-guided triage decisions for patients with urinary tract infections.

Authors:  A Litke; R Bossart; K Regez; U Schild; M Guglielmetti; A Conca; P Schäfer; B Reutlinger; B Mueller; W C Albrich
Journal:  Infection       Date:  2013-02-24       Impact factor: 3.553

3.  52-year follow-up of a birth cohort reveals a high pneumonia incidence among young men.

Authors:  Pia Holma; Paula Pesonen; Olli Mustonen; Marjo-Riitta Järvelin; Heikki Kauma; Juha Auvinen; Timo Hautala
Journal:  ERJ Open Res       Date:  2022-06-27

4.  Which patients with lower respiratory tract infections need inpatient treatment? Perceptions of physicians, nurses, patients and relatives.

Authors:  Claudia Baehni; Sabine Meier; Pamela Spreiter; Ursula Schild; Katharina Regez; Rita Bossart; Robert Thomann; Claudine Falconnier; Mirjam Christ-Crain; Sabina De Geest; Beat Müller; Philipp Schuetz
Journal:  BMC Pulm Med       Date:  2010-03-11       Impact factor: 3.317

5.  The value of prognostic indices for pneumonia.

Authors:  Jennie Johnstone; Sumit R Majumdar; Thomas J Marrie
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

6.  Predictors for length of hospital stay in patients with community-acquired pneumonia: results from a Swiss multicenter study.

Authors:  Isabelle Suter-Widmer; Mirjam Christ-Crain; Werner Zimmerli; Werner Albrich; Beat Mueller; Philipp Schuetz
Journal:  BMC Pulm Med       Date:  2012-05-20       Impact factor: 3.317

7.  Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial.

Authors:  Daniel Drozdov; Anja Thomer; Marc Meili; Stefanie Schwarz; Rita Bossart Kouegbe; Katharina Regez; Merih Guglielmetti; Ursula Schild; Antoinette Conca; Petra Schäfer; Barbara Reutlinger; Cornelia Ottiger; Florian Buchkremer; Alexander Litke; Philipp Schuetz; Andreas Huber; Ulrich Bürgi; Christoph A Fux; Andreas Bock; Beat Müller; Werner C Albrich
Journal:  Trials       Date:  2013-03-22       Impact factor: 2.279

8.  Impact of admission blood glucose level on outcomes in community-acquired pneumonia in older adults.

Authors:  Rajib K Bhattacharya; Jonathan D Mahnken; Sally K Rigler
Journal:  Int J Gen Med       Date:  2013-05-06

9.  Effectiveness of Proadrenomedullin Enhanced CURB65 Score Algorithm in Patients with Community-Acquired Pneumonia in "Real Life", an Observational Quality Control Survey.

Authors:  Daniel Widmer; Daniel Drozdov; Kristina Rüegger; Alexander Litke; Birsen Arici; Katharina Regez; Merih Guglielmetti; Ursula Schild; Antoinette Conca; Petra Schäfer; Rita Bossart Kouegbe; Barbara Reutlinger; Claudine Blum; Philipp Schuetz; Sarosh Irani; Andreas Huber; Ulrich Bürgi; Beat Müller; Werner C Albrich
Journal:  J Clin Med       Date:  2014-03-14       Impact factor: 4.241

10.  Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial.

Authors:  Werner C Albrich; Kristina Rüegger; Frank Dusemund; Philipp Schuetz; Birsen Arici; Alexander Litke; Claudine A Blum; Rita Bossart; Katharina Regez; Ursula Schild; Merih Guglielmetti; Antoinette Conca; Petra Schäfer; Maria Schubert; Sabina de Geest; Barbara Reutlinger; Sarosh Irani; Ulrich Bürgi; Andreas Huber; Beat Müller
Journal:  Eur Respir J       Date:  2013-01-24       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.